| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | 90,010 | $50 | $4.7M |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | 56,220 | $60 | $3.5M |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | 52,790 | $40 | $2M |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 491,120 | $1 | $1.5M |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 143,320 | $10 | $1.4M |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 243,650 | $1 | $731K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 280,360 | $1 | $560.7K |
| G0333 | Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary | 22,310 | $10 | $133.8K |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 35,760 | $1 | $71.5K |
| Q0514 | Pharmacy dispensing fee for inhalation drug(s); per 90 days | 6,280 | $10 | $44K |